Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.

Pathology - 1 Feb 2012

Tzvetkov Mladen, von Ahsen Nicolas

Abstract excerpt

Pharmacogenetics has substantially added to our understanding of the variability of drug response. A number of single gene markers have been established and are ready to use in clinical practice. Here we review the validity and utility of markers in a number of genes (CYP2D6, CYP2C19, CYP2C9, VKO...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Drug Therapy
Share to TPMT gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to VKORC1 gene

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Mass Screening

Share to Pharmacogenetics

Source

Identifiers

PMID: 22228255
DOI: 10.1097/PAT.0b013e32834f4d69

Genes

KRAS
TPMT
VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22228255-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.PMID 22228255Read ↗

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Semantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

Pharmacogenetics in clinical practice: how far have we come and where are we going?Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: using genetic information to guide therapeutic decision making.Semantic proximity Read ↗

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.Semantic proximity Read ↗

Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation PerspectivesSemantic proximity Read ↗

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsSemantic proximity Read ↗

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.Semantic proximity Read ↗

Pharmacogenomics: Current State-of-the-ArtSemantic proximity Read ↗

Pharmacogenomics guidelines: Current status and future developmentSemantic proximity Read ↗

Pharmacogenomics: Challenges and OpportunitiesSemantic proximity Read ↗

Pharmacogenomics in the era of next generation sequencing – from byte to bedsideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.